Mirae Asset Global Investments Co. Ltd. decreased its holdings in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 7.5% during the 4th quarter, according to its most recent 13F filing with ...
The stock market heads into an interesting round of earnings, led by Walmart, RIvian, and a key Warren Buffett stock.
Guardant Health (GH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...
After losing some value lately, a hammer chart pattern has been formed for Guardant Health (GH), indicating that the stock has found support. This, combined with an upward trend in earnings estimate ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating ...
Guardant Health (NASDAQ:GH), a $5.49 billion market cap healthcare company, announced a significant step in its financial strategy, reaching an agreement to exchange a portion of its convertible notes ...